Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease

Brain Research

Volumn 498, Issue 1, 1989, Pages 185-189

  Geula, Changiz ^a,b   Mesulam, Marsel ^a,b  

^a Division of Neuroscience and Behavioral Neurology Bullard and Denny Brown Laboratories Department of Neurology ^*  (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 BIS(4 ALLYLDIMETHYLAMMONIUMPHENYL)PENTAN 3 ONE DIBROMIDE; ACETYLCHOLINESTERASE; CHOLINESTERASE; ISO OMPA;

ALZHEIMER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BUTYRYLCHOLINESTERASE; BW 284 C 51; CHOLINESTERASES; ENZYME INHIBITORS; FEMALE; HISTOCYTOCHEMISTRY; HUMAN; HYDROGEN-ION CONCENTRATION; MALE; NEUROFIBRILS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRAISOPROPYLPYROPHOSPHAMIDE;

EID: 0024417125     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(89)90419-8     Document Type: Article

References (21)

1. Changes of biogenic amines and their metabolites in postmorten brains from patients with Alzheimer-type dementia
2. Have cholinesterases more than one function?
3. Somatostatin-28(1–12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex
4. Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex
5. Neuropeptide Y immunoreactivity is reduced in Alzheimer's disease cerebral cortex
6. Alzheimer's disease: enter a protease inhibitor
7. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease
8. Serotonin receptor changes in dementia of the Alzheimer type
9. Neurotransmitter related enzymes in senile dementia of the Alzheimer type
10. Enzyme histochemical studies of senile plaques
11. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex
12. Diagnosis of Alzheimer's disease
13. Evidence for cholinergic neurites in senile plaques
14. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroamino-acridine on plaques and tangles
15. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease
16. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients
17. Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia
18. Histochemical observations on the cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients
19. Acetylcholinesterase exhibits trypsin-like and metalloexopeptidase-like activity in cleaving a model peptide
20. Acetylcholinesterase fibers and the development of senile plaques
21. Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy